WeVote

Bill

Bill

S 1965

Regulates provision of pharmaceutical services in long-term care facilities.

2024-2025 Regular Session Introduced by Renee Burgess and 4 co-sponsors

New Jersey bill establishes pharmaceutical service standards for long-term care facilities to enhance medication safety and oversight for nursing home residents.

Reported out of Assembly Committee, 2nd Reading
0
WeVote Research Nonpartisan
Bill Summary · S 1965

Legislative bill overview

S 1965 establishes regulatory standards for pharmaceutical services provided within New Jersey's long-term care facilities, including nursing homes and assisted living communities. The bill sets requirements for how medications are dispensed, managed, and monitored in these settings to ensure resident safety and medication accuracy.

Why is this important

Long-term care residents are typically elderly and often take multiple medications, making them vulnerable to medication errors that can cause serious harm or death. Strengthening pharmaceutical oversight in these facilities directly protects a vulnerable population while potentially reducing hospitalizations and improving health outcomes.

Potential points of contention

  • Implementation costs: New regulations may require facilities to invest in updated pharmacy systems, staff training, or additional personnel, with costs potentially passed to residents or their insurers
  • Staffing burden: Enhanced pharmaceutical oversight requirements could strain already-tight staffing in facilities experiencing widespread nursing shortages
  • Prescriber coordination: The bill may create friction between facility pharmacists and resident physicians regarding medication management authority and decision-making processes
  • Small facility compliance: Smaller long-term care operators may face disproportionate regulatory compliance challenges compared to larger corporate chains

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.